GlassScriptPhysician profile
Jalpa Patel
NPI 1134862915
$1,309.59
in general payments reported to CMS, 2019-2025
18 companies · $135 in 2025
The $135 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $232 · 2023: $499 · 2024: $443 · 2025: $135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,078.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,077.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $222.42 | 2024-2025 | Interstim |
| Sumitomo Pharma America, INC. | $189.71 | 2023-2024 | Orgovyx |
| Myovant Sciences INC. | $130.01 | 2022 | |
| Janssen Pharmaceuticals, INC | $124.99 | 2024 | Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $123.99 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $103.08 | 2023-2025 | Lynparza, Breztri |
| Endo Pharmaceuticals INC. | $90.64 | 2022-2024 | Aveed, Xiaflex |
| Tolmar, INC. | $73.08 | 2023 | |
| Olympus America INC. | $58.95 | 2023-2025 | Itind System, Soltive |
| Baxter Healthcare | $26.77 | 2025 | Tisseel |
| Amgen INC. | $24.36 | 2023 | Prolia |
| Blue Earth Diagnostics | $23.26 | 2023 | |
| Tolmar Pharmaceuticals, INC. | $21.39 | 2022 | |
| Boston Scientific Corporation | $20.94 | 2024 | Greenlight Xps |
| Urovant Sciences INC | $20.30 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $19.78 | 2023 | |
| Procept Biorobotics Corporation | $18.88 | 2023 | Aquabeam Robotic System |
| Astellas Pharma US INC | $17.04 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jalpa Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.